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ABSTRACT 
 
A method was developed to assess the functional significance of a sequence motif in yeast Upf3p, a protein required for nonsense-
mediated mRNA decay (NMD). The motif lies at the edge of the Upf3p-Upf2p interaction domain, but at the same time resembles the 
canonical leucine-rich nuclear export sequence (NES) found in proteins that bind Crm1p exportin. To test the function of the putative 
NES, site-directed mutations that cause substitutions of conserved NES-A residues were first selected to identify hypermorphic alleles. 
Next, a portable Crm1p-binding NES from HIV-1 Rev protein that functions in yeast was fused en masse to the C-terminus of variant 
Upf3 proteins using loxP sites recognized by bacterial cre-recombinase. Finally, variant Upf3-Rev proteins that were functional in NMD 
were selected and examined for the types of amino acid substitutions present in NES-A. The mutational analysis revealed that amino 
acid substitutions in the Upf3 NES impair both nuclear export and the Upf2p-Upf3p interaction, both of which are required for Upf3p 
to function in NMD. The method described in this report could be modified for the genetic analysis of a variety of portable protein 
domains. 
 
 
INTRODUCTION 
 
UPF3 is one of three genes in the yeast Saccharomyces cerevisiae that 
is required for the nonsense-mediated mRNA decay pathway 
(NMD) (1-5) Aberrant mRNAs where translation is prematurely 
terminated become substrates in the NMD pathway and are 
rapidly degraded. Mutations in UPF3 stabilize nonsense mRNAs 
resulting in rates of decay similar to wild-type transcripts (5). We 
identified a sequence motif in Upf3p called NES-A that 
resembles the canonical leucine-rich nuclear export sequence 
(NES) found in many other proteins that binds to Crm1p, the 
exportin that carries cargo through nuclear pores into the 
cytoplasm (6). However, NES-A is located in a complex region at 
one edge of a domain that mediates a protein-protein interaction 
between Upf3p and Upf2p. This region also shows weak 
sequence similarity to canonical RNA recognition domains 
(RRM) (6, 7). 
 
The segment containing NES-A was shown to direct a nuclear-
localized reporter to the cytoplasm (6). Alanine substitutions of 
evolutionarily conserved leucine and isoleucine residues in NES-
A abolished export of the same reporter. Three simultaneous 
alanine substitutions in NES-A (upf3-triple) inactivated NMD and 
caused the accumulation of Upf3p in the nucleolus, a region 
within the nucleus. These findings support a role for NES-A in Shirley et al.    
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nuclear export. However, there were three unexplained features 
of NES-A that distinguished it from the canonical NES known 
to drive export of other proteins (6, 7). Although the NES-A 
sequence matches the consensus leucine-rich NES sequence, it is 
present in reverse orientation relative to the N- and C- terminus 
compared to all other NES domains that direct export. Also, the 
canonical NES binds to the Crm1p exportin (8-10), but Upf3p is 
not dependent on Crm1p for export and presumably does not 
bind to Crm1p. Finally, when export was fully restored by adding 
a heterologous NES at the C-terminus of Upf3-Triple, NMD was 
only partially restored, suggesting that NES-A may have one or 
more functions in addition to promoting export (6). 
 
In order to resolve these conflicting observations and to separate 
the possible functions of NES-A, we developed a unique way to 
analyze mutations in NES-A. The method, which we refer to as 
the dual selection for loss/regain of function, requires two steps. 
The first is a selection for mutations in NES-A that impair the 
function of UPF3. The second step is based on the observation 
that the canonical leucine-rich NES is a self-contained and 
portable binding site for Crm1p (10). Mutations in NES-A that 
specifically impair NMD by blocking Upf3p export were 
identified by fusing a bona fide Crm1p-binding NES to the mutant 
Upf3p proteins and then selecting for those that regain function 
in NMD. 
 
To accomplish this, we utilized the cre-lox recombination system 
commonly used for genomic manipulation. Cre-mediated 
recombination between loxP sites has been used successfully to 
eliminate or activate gene expression in a tissue-specific and time-
specific manner, reduce the number of copies of integrated 
transgene arrays, and to direct the site-specific insertion of 
transgenes (11, 12). In our system, we used cre-lox recombination 
to cause a fusion of the leucine-rich NES from the mammalian 
HIV-1 Rev protein (13-16), which directs export in yeast, to the 
C-terminus of Upf3 mutant proteins. Two loxP sites were 
positioned such that induction of cre-recombinase eliminated the 
intervening sequence resulting in an in-frame translational fusion 
between sequences coding for the Rev NES and Upf3p. 
Following recombination, the alleles were analyzed to see if 
defects in nuclear export and NMD were corrected by the C-
terminal addition. 
 
In this report we focus on the details of the two-step selection 
and describe the characterization of three mutations causing 
amino acid substitutions in NES-A that impair the function of 
Upf3p. We suggest that a similar approach could yield valuable 
information when applied to the analysis of other sequence 
motifs and domains in other proteins.  
 
MATERIALS AND METHODS 
 
Strains, genetic methods, and supplemental 
information   
 
Strain RSy5 (MATα ade2-1 leu2-1 tyr7-1 can1-100 upf3-∆1 trp1 ura3 
his3 GAL2), which carries a null allele of UPF3 (7), was used as a 
transformation recipient in the dual selection for loss/regain of 
function. Further information on plasmids, strains, and mutant 
alleles of UPF3 beyond what is described in this report can be 
found in Shirley et al. (7). Yeast was transformed by 
electroporation (17), which is described in the Protocol section. 
Supplemental information including the complete sequences for 
the plasmids pRR2 and pRLS207 described below can be found 
at http://www.molbio.wisc.edu/culbertson/creloxplasmids/.  
 
cre/lox-mediated recombination of plasmid pRR2 
 
The plasmid pRR2 (Figs. 1 and 3) was designed to analyze the 
functional effects of mutations in NES-A. pRR2 contains two 
loxP recognition sites oriented in the same direction. In cells 
expressing the site-specific cre-recombinase, double-strand breaks 
occur at both loxP sites. The free DNA ends recombine, resulting 
in a re-circularized plasmid in which the DNA between the two 
loxP sites is deleted. Recombination also results in the deletion of 
one of the loxP sites. loxP sites must be in the same orientation in 
order to delete the intervening segment. If they are in opposite 
orientation, recombination causes an inversion of the intervening 
segment. In pRR2, one loxP site is located within the UPF3 open 
reading frame directly 5' of the stop codon (designated UPF3-
loxP). The second loxP site is located 5' of sequences coding for a 
functional leucine-rich NES from the viral HIV-1 Rev protein 
and the 3'-UTR of UPF3 (loxP-Rev-UTR). In S. cerevisiae, the HIV-
1 Rev-NES domain binds to yeast Crm1p and promotes the 
nuclear export of any protein to which the NES is fused (8, 9). 
Expression of cre-recombinase results in the excision of the DNA 
sequence between the loxP sites and the fusion of the Rev-NES 
and  UPF3 3'-UTR to UPF3-loxP. The recombined plasmid 
expresses a version of Upf3p that has a functional NES at the C-
terminus. The pre-recombined UPF3-loxP and post-recombined 
UPF3-loxP-Rev alleles both express functional versions of an 
otherwise wild-type Upf3p as evidenced by the ability of UPF3-
loxP and UPF3-loxP-Rev to complement a upf3-∆1 null allele (data 
not shown). Plasmid-mediated complementation was assayed by 
suppression of nonsense mutations and by accumulation of 
CYH2 pre-mRNA as described below. The S. cerevisiae ADE2 
gene is located in the segment between the two loxP sites. In the 
ade
- strain RSy5, the ADE2 gene on the plasmid allows selection 
of the pre-recombined plasmid and the ability to monitor 
recombination following cre expression (Fig. 3). Colonies 
expressing the pre-recombined UPF3-loxP  plasmid are white. 
After recombination and excision of the ADE2 gene, colonies 
turn red because ade2 mutants accumulate a red pigment.  
 
The pRR2 plasmid, which was constructed starting with the 
vector pRS316 (7, 18), is a single copy plasmid containing an S. 
cerevisiae origin of replication (ARS4), the centromere of S. 
cerevisiae chromosome IV (CEN4), and the S. cerevisiae URA3 gene 
which confers selective growth of Ura+ transformants in medium 
lacking uracil. pRR2 carries a bacterial ampicillin resistance gene 
and the pBR322 origin of replication allowing selection of E. coli 
transformants.  Shirley et al.    
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Expression of cre recombinase 
 
Plasmid pRLS207 expresses cre, the site-specific recombinase 
from bacteriophage P1 (19) (Fig. 1). In pRLS207, the cre open 
reading frame is flanked by the S. cerevisiae GAL1 promoter and 
CYC1 transcription termination signal sequence. When cells 
harboring pRLS207 are grown in glucose, GAL1
P-cre-CYC1
T is 
not expressed, but in the presence of galactose transcription is 
induced. pRLS207, which was constructed starting with the 
vector pRS423 (18) is a multicopy plasmid carrying the origin of 
replication from the S. cerevisiae 2µm endogenous plasmid and the 
yeast  HIS3 gene, which confers selective growth of His+ 
transformants in medium lacking histidine. pRLS207 carries the 
ampicillin resistance gene and the pBR322 origin of replication 
allowing selection of E. coli transformants. 
 
 
Fig. 1: Plasmids used in the dual screen for loss/regain of function. Both 
plasmids are circular with critical elements shown in linear format. Both plasmids 
are shuttle vectors that replicate in both yeast and E. coli (A) The diagram shows 
the organization of elements important for expression of cre recombinase in 
pRLS207. (B) The diagram shows the organization of elements in pRR2 used in 
mutagenisis and cre-mediated recombination. Wild-type amino acids targeted by 
mutagenesis are shown in red. 
 
Phenotypic assays  
 
The phenotypes of mutations in NES-A were assessed by three 
different assays: growth tests (suppression of nonsense 
mutations), accumulation of a pre-mRNA whose abundance and 
stability depends on UPF3 function, and cytological localization 
of the protein products of mutant upf3 alleles. All three assays 
summarized here are described in greater detail in previous 
reports (6, 7). 
 
Nonsense suppression was monitored in strains carrying the leu2-
1 (UAA) and tyr7-1 (UAG) nonsense mutations, which prevent 
growth on medium lacking leucine and tyrosine. Mutations in 
UPF3 that cause loss of function suppress leu2-1 and tyr7-1 and 
allow growth on medium lacking leucine and tyrosine. The can1-
100 (UAA) nonsense mutation confers resistance to canavanine 
(Canr) in a wild-type UPF3 strain, whereas loss-of-function 
mutations in UPF3 suppress can1-100 and confer sensitivity to 
canavanine (CanS). In each of these three cases, suppression 
results from increased stability of the nonsense mRNA and from 
increased read-through of translation termination at the 
premature stop codon. 
 
CYH2 coding for ribosomal protein L29 contains an intron that 
is inefficiently spliced (20). An in-frame stop codon at position 
19 in the intron triggers rapid decay of unspliced pre-mRNA 
(21). The pre-mRNA accumulates to a 5-6 fold higher level in 
upf3
- strains due to an increase in the pre-mRNA half-life but 
without any change in the mature mRNA half-life. The CYH2 
pre-mRNA/mRNA ratio therefore provides a quantitative 
assessment of function of the NMD pathway. Methods for 
quantitative measurement of RNA accumulation using Northern 
blotting are described by Leeds et al. (1) and Atkin et al. (22). To 
determine relative accumulation, the CYH2 pre-mRNA/mRNA 
ratio in upf3 mutants was normalized to the ratio in a wild-type 
UPF3 strain to calculate the fold change. Fold changes were 
averaged across three or more trials and evaluated statistically as 
described previously (7). 
 
Epitope-tagged Upf3p was visualized by immunofluorescence. 
Early log phase cells were processed as described previously (6, 
23). The ability of mutant Upf3 proteins to interact with Upf2p 
was assayed using the yeast two-hybrid system as described by 
James et al. (24). The details of the two hybrid experiments are 
described by Shirley et al. (7). The results are not presented in 
detail here but are summarized in Table 2. 
 
Mutagenesis 
 
Multi-round PCR was used to generate mutations in the 
sequences coding for residues L88, I90, L92 and L93 in NES-A 
(Fig. 2). The mutagenic oligonucleotide RR03 was degenerate for 
nucleotides in each of four codons such that the mutations in 
each codon could potentially result in 15 different amino acid 
substitutions (not including Met ,  P h e ,  T y r ,  C y s ,  a n d  T r p ) .  
Variants where U was the first nucleotide of a codon were 
avoided so that UAA, UAG, and UGA termination codons 
would not be generated. Alternative schemes designed to 
produce all 20 amino acid substitutions were not attempted 
because they necessitate the inclusion of stop codons. 
 
In the first round of PCR, oligonucleotides primers RRO3 and 
LSO183 (Fig. 2) and template plasmid pLS17 (CEN URA3 
UPF3) (7) were used to amplify DNA fragments containing 
random mutations at each of the four codons. The first-round 
PCR products were used as a megaprimer in the second round 
along with oligonucleotide T7 (Fig. 2) and template pLS17. The 
PCR fragments amplified in the second round contained 
recognition sites for SnaBI and SacII. After digestion with these 
enzymes, the resulting DNA fragments were used to replace the 
SacII–SnaBI fragment containing wild-type NES-A in plasmid 
pRR2. Shirley et al.    
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Fig. 2: Strategy for mutagenesis of NES-A in pRR2 using multi-round 
PCR. The structure of UPF3 is shown at the top including known or suspected 
domains: NLS, nuclear localization signal sequence; Upf2p binding, the region 
required for binding to Upf2p; RRM, a region showing similarity to an RNA 
recognition motif identified in studies of the human ortholog to yeast Upf3p (27); 
NES-A, the motif resembling the leucine-rich nuclear export domain 
corresponding to the binding domain for the exportin Crm1p. 
 
The ligation reaction between SacII-SnaBI PCR fragments and 
SacII-SnaBI-digested pRR2 was transformed into XL10-Gold 
ultra-competent E. coli cells (Stratagene, La Jolla, CA) and plated 
on standard Luria-Bertani (LB) medium plus 100 µg/ml 
ampicillin. Plasmid DNA isolated from pools of E. coli 
transformants were used to transform yeast strain RSy5 as 
described below. The number of E. coli transformants to be 
pooled in order to obtain with 95% confidence every possible 
amino acid combination caused by the mutagenic oligonucleotide 
was estimated using the formula:  
 
) / 1 ln(
) 1 ln(
T n
P
N
−
−
=  
 
where P = the probability that each combination of amino acid 
substitutions will be represented once, N = the number of 
bacterial colonies pooled, n = the number of the rarest 
combination, and T = the total number of combinations. Since 
some of the amino acids are represented by only one of the 24 
possible codon combinations, 70 colonies must be pooled in 
order to have a 95% probability of obtaining at least one of each 
of the 24 combinations at a given codon. This assumes that each 
combination is represented equally after PCR amplification, 
which might not occur if any fragments are preferentially 
amplified. When four codons are mutated, a pool of ~106 E. coli 
transformants would be required to ensure detection of the rarest 
combinations. In the experiments described below, we pooled far 
fewer than this number and did not, therefore, exhaust the 
potential to uncover mutants of interest. In designing a screen of 
this type, there are trade offs between the advantages of mutating 
multiple codons and the disadvantages of needing to screen large 
numbers of transformants to recover all possible mutant 
combinations. 
 
RESULTS AND DISCUSSION 
 
Rationale 
 
The combined mutagenesis and dual selection requires five steps 
(Figs. 2 and 3): (1) mutagenic PCR to create mutations in pre-
chosen residues in NES-A, (2) selection for yeast co-
transformants that carry both a mutagenized pRR2 plasmid and 
the pRSL207 plasmid that codes for cre-recombinase, (3) plate 
tests for loss of function before recombination, (4) induction of 
cre-mediated plasmid recombination that places the HIV-1 Rev-
NES at the C-terminus of mutant Upf3 proteins, and (5) plate 
tests to assess whether the C-terminal Rev NES improves 
function. 
 
Fig. 3: Design of the dual screen for loss/regain of function. Recombination 
mediated by bacterial cre recombinase expressed in yeast places a function nuclear Shirley et al.    
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export sequence (NES) derived from the mammalian HIV-1 Rev protein at the 
C-terminus of mutant Upf3p. Regain of function after recombination implies that 
a mutation in the Upf3p NES motif impairs nuclear export and that nuclear 
export is required for the function of Upf3p. The petri plates shown at the 
bottom represent idealized results. Loss of function is indicated by co-
suppression of leu2-1 tyr7-1 (white colonies before recombination that grow in the 
absence of leucine and tyrosine) and suppression of can1-100 (grey imprints of 
colonies that fail to grow). Regain of function after recombination is indicated by 
loss of suppression allowing growth in the presence of canavanine (red colonies). 
White colony color results from the presence of the ADE2 gene on plasmid 
pRR2 before recombination and red colony color results from deletion of the 
ADE2 gene after recombination. The cre-recombinase expressed from plasmid 
pRLS207 is controlled by the GAL1 promoter and is induced with galactose as 
carbon source. 
 
Since mutant alleles were identified based on loss and regain of 
function of mutant Upf3 proteins in the absence or presence of 
C-terminal additions, respectively, it was important to determine 
whether the additions of loxP and Rev NES affect function by 
themselves. The addition of an HA epitope at the N-terminus 
was known to cause a slighty impairment of Upf3 function (6). 
 
Appropriate alleles were tested for their ability to complement a 
upf3-∆1 null allele as measured by  nonsense suppression and 
CYH2 pre-mRNA accumulation (see below). The C-terminal 
addition of loxP and the HIV-1 Rev-NES had no significant 
effect on the function of wild-type Upf3p (data not shown), 
indicating that the NMD phenotype of the mutant Upf3-loxP 
and Upf3-loxP-Rev proteins would be due solely to their amino 
acid substitutions in NES-A. 
 
Dual selection for loss/regain of function 
 
Plasmid DNA was isolated from a pool of ~8,600 E. coli 
transformants carrying PCR-mutagenized pRR2 plasmids. The 
pRR2 DNA was mixed with pRLS207 plasmid DNA and used to 
co-transform strain RSy5 (MATα  ade2-1  leu2-1  tyr7-1  can1-100 
upf3-∆1 trp1 ura3 his3
 GAL2) to a Ura+ His+ phenotype (pRR2 
carries URA3 and pLRS207 carries HIS3, see Fig. 1). Omission 
of adenine in the growth medium and white colony color ensured 
that transformants contained pre-recombined plasmids. 
Transformants were plated directly onto medium lacking uracil, 
histidine, adenine, leucine and tyrosine in order to select for 
transformants harboring pRR2 plasmids that suppress the tyr7-1 
and  leu2-1 nonsense mutations. Out of ~84,000 yeast 
transformants plated, 7,200 had a Tyr+ Leu+ phenotype, 
indicating that at least one mutation causing impairment of UPF3 
function was carried on the pRR2 plasmids.  
 
Two alternative approaches can be used to analyze the Tyr+ Leu+ 
transformants. The transformants can be replica-plated to 
medium containing canavanine. Complete loss of UPF3 function 
leads to a CanS phenotype due to suppression of the canavanine 
resistant nonsense allele can1-100. Mutations that partially impair 
function cause an intermediate phenotype of weak resistance 
(increased sensitivity) compared to wild-type. The strength of the 
phenotype can be adjusted by varying the concentration of 
canavanine. Growth on canavanine prior to recombination can 
be compared to growth of the transformants on canavanine 
following  cre-mediated recombination between the loxP sites. 
Recombination can be induced by replica-plating the Tyr+ Leu+ 
transformants to medium containing galactose to activate the 
expression of cre. In a second approach, the phenotypic analysis 
of primary transformants on canavanine before recombination 
can be skipped. Primary transformants can be replica-plated 
directly to medium containing galactose to induce recombination 
and then to plates containing canavanine. Using the latter 
approach, we identified 389 canr colonies from the original 7,200 
transformants. 
 
Table 1: Amino acid substitutions in NES-A. 
Allele  NES-A amino acid 
sequence 
Percent function in 
NMD* 
UPF3  88-LVI RLLPPNL-97  100 
upf3-Triple-HA  L88A I90A L93A  25 
upf3-nes1  L88V I90V L92G L93V  87 
upf3-nes2  L88D I90A L92G L93S  46 
upf3-nes3  L88N I90D L93R  nd 
upf3-nes4  L88V I90V L93G  nd 
upf3-nes5  L88R I90L L92G L93S  37 
upf3-nes6  L88G I90V L92P L93K  36 
upf3-nes7  L88Q I90R L92V L93G  27 
*The percent function was determined using the CYH2 assay for pre-mRNA     
accumulation (Materials and Methods and (7)). 
 
The mutations in the pRR2 plasmids from seven of these 
transformants were analyzed by sequence analysis of PCR-
amplified DNA fragments (Table 1, (7)). All seven transformants 
were chosen based on their robust growth on medium lacking 
leucine and tyrosine and on medium containing canavanine prior 
to and after cre-induced recombination, respectively. The seven 
alleles designated upf3-nes1 through upf3-nes7 contained three to 
four amino acid substitutions of the conserved leucine and 
isoleucine residues in NES-A (Table 1). The amino acid 
substitutions were analyzed by replacing the wild-type NES in 
Upf3p with each of the seven NES variants to quantitate their 
extent of NMD impairment. Quantifying the CYH2 pre-
mRNA/mRNA ratio in transformants carrying the upf3 alleles 
revealed that the ability of the mutant proteins to function in 
NMD ranged from 27% to 87% compared to wild-type Upf3p 
(Table 1).  
 
Phenotypic analysis of selected mutants 
 
The genetic, molecular, and cytological phenotypes of two alleles, 
upf3-nes2 (L88D I90A L92G L93S) and upf3-nes7 (L88Q I90R 
L92V L93G) were characterized in the presence or absence of a 
functional NES at the C-terminus (Table 2). In this analysis we 
included a previously described allele called upf3-Triple (L88A 
I90A L93A) (7). We reported previously that Upf3p-Triple 
tagged with the HA epitope was reduced in abundance compared 
to Upf3p-HA by 50% (6). To increase the abundance of the 
mutant protein to a level similar to Upf3p-HA, the experiments 
were done using a plasmid that carries two copies of the upf-
Triple-HA gene, which results in two-fold over-expression of the 
mutant protein (6). The upf3-nes2-HA and upf3-nes-HA alleles 
produced proteins that were similar in abundance to the wild-
type protein when present in a single gene copy. Shirley et al.    
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Table 2: Phenotypic properties of NES-A mutants. 
UPF3 allele  NES-A amino acid 
substitutions 
Nonsense 
suppression 
Percent function in      
NMD** 
Nuclear export 
defect*** 
Upf2/Upf3 
interaction**** 
UPF3 (wild-type)  88-LVI RLLPPNL-97  −  100 no  ++ 
upf3- ∆1 (null)  no protein made  +++  0  N/A  N/A 
upf3-Triple-HA  L88A I90A L93A  ++  25  yes  - 
upf3-Triple-HA-Rev   +  46  no  ND 
upf3-Triple-HA-M10   ++  25  yes  ND 
upf3-nes2  L88D I90A L92G L93S  +  46  yes  - 
upf3-nes2-Rev   +  46  no  ND 
* “+++” represents full suppression of the leu2-1 and tyr7-1 nonsense alleles characteristic of the upf3-∆1 null allele. “–“ indicates the complete lack of suppression 
characteristic of wild-type UPF3. “+” and “++” indicate weaker and stronger levels of suppression intermediate between upf3-∆1 and UPF3. 
 
**The percent function was determined using the CYH2 assay for pre-mRNA accumulation (Materials and Methods and (7)). 
 
***Epitope-tagged Upf3 proteins were localized by immunofluorescence microscopy (Materials and Methods and (7)). Wild-type Upf3p was visualized throughout the 
cytoplasm with no staining detected in the nucleus (6, 7). A defect in nuclear export was indicated by the increase in nucleolar accumulation (7). 
 
****The ability of the Upf3 proteins to interact with Upf2p was assayed using the yeast two-hybrid system (7). “++” and “-“ indicate robust growth and lack of 
growth, respectively, on selective media. ND = Not Determined. 
 
The  upf3-nes2,  upf3-nes7, and upf3-Triple-HA alleles all cause 
suppression of the leu2-1,  tyr7-1, and can1-100 nonsense 
mutations, but the efficiency of suppression was less than that of 
upf3-∆1 (Table 2, (6)).The growth tests suggest that all three 
alleles cause partial impairment of function. When DNA coding 
for the HIV-1 Rev NES was present following the last codon of 
each mutant gene, the level of suppression was unchanged for 
upf3-nes2 and upf3-nes7, but was reduced for upf3-Triple-HA. This 
suggests that the functional impairment caused by the nes2 and 
nes7 amino acid substitutions was unaltered when a functional 
NES is added to the C-terminus, whereas the functional 
impairment caused by the triple alanine substitutions is partially 
alleviated by the C-terminal addition. 
 
To quantitate the effects of the mutations in the presence and 
absence of a C-terminal NES, the CYH2 pre-mRNA/mRNA 
ratio was determined (Table 2, (6)). The upf3-nes2 and upf3-nes7 
alleles produce proteins that were 46% and 27% as functional as 
wild-type Upf3p, respectively (Table 2). The addition of a 
functional NES at the C-terminus caused no change in the CYH2 
pre-mRNA/mRNA ratio. However, the addition of a C-terminal 
NES to the Upf3-Triple-HA protein improved function from 
25% to 46% (Table 2). To verify that the improved function was 
due to the addition of a functional C-terminal NES, a control 
experiment was done using the HIV-1 Rev-M10, which carries a 
mutation that abolishes the ability of the NES to promote 
nuclear export. There was no change in the CYH2 pre-
mRNA/mRNA ratio when HIV-1 Rev-M10 was placed at the C-
terminus of Upf3-Triple-HA (Table 2). 
 
To examine the effects of the mutations on nuclear export, HA-
tagged versions of the mutant proteins were localized by 
immunofluorescence using HA monoclonal antibodies (Table 2, 
(6)). In wild-type strains, Upf3p-HA localizes to the cytoplasm 
without any detectable signal in the nucleus. However, nuclear  
 
 
 
Upf3p-HA is detected either when the wild-type protein is over-
expressed or when mutant Upf3p-HA is impaired in its ability to 
export from the nucleus. Under these circumstances, the 
immunofluorescent signal is concentrated in the nucleolus. Since 
the nucleolus is a sub-region within the nucleus, nucleolar 
accumulation serves as a marker for impaired nuclear export. 
HA-tagged versions of upf3-nes2,  upf3-nes7,  and upf3-Triple-HA 
produced proteins that accumulate in the nucleolus with some 
Upf3p still detectable in the cytoplasm. These results are 
consistent with the hypothesis that the functional impairment of 
the alleles in NMD is caused at least in part by a defect in nuclear 
export. 
 
To ask whether the HIV-1 Rev-NES restores nuclear export 
when added to the C-terminus, we analyzed Upf3p-Triple-HA, 
Upf3p-Triple-HA-M10 (non-functional NES), and Upf3p-Triple-
HA-Rev (functional NES) by immunofluorescence (Table 2, (6)). 
The nucleolar signal indicative of an export defect was detected 
in cells carrying the upf3-Triple-HA and upf3-Triple-HA-M10 
alleles. However, the nucleolar signal was abolished in cells 
carrying the upf3-Triple-HA-Rev allele. This evidence supports the 
conclusion that the HIV-1 Rev-NES restores the ability of 
Upf3p-Triple to export from the nucleus to the cytoplasm. 
However, the restoration of export results in only a partial 
restoration of function in NMD as determined by the 
suppression and mRNA accumulation tests described above. 
 
The NES-A region was shown previously to be important but 
not sufficient for the protein-protein interaction known to occur 
between Upf2p and Upf3p (7, 25). The ability of Upf3-Triple, 
Upf3-nes2, and Upf3-nes7 proteins to interact with Upf2p was 
determined using the yeast two-hybrid system. All three mutant 
proteins expressed with Upf2p failed to promote growth on 
selective media indicating a significant decrease in the strength of 
the interaction (Table 2, (7)). 
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To summarize, the triple alanine substitutions cause partial loss 
of function without the C-terminal HIV-1 Rev-NES and partial 
regain of function when the C-terminal NES is present. The upf3-
nes2 and upf3-nes7 alleles also cause partial loss of function where 
upf3-nes2 is less impaired than upf3-Triple-HA and upf3-nes7. 
However, both alleles differ from upf3-Triple-HA in that a partial 
re-gain of protein function does not occur in the presence of a C-
terminal NES. All three alleles produce a protein that is impaired 
for export and for the physical interaction with Upf2p. Overall, 
the results suggest either that the export of Upf3p occurs by 
binding to Upf2p or a specific export pathway for Upf3p is 
necessary to promote an interaction with Upf2p. 
 
Recently, the crystal structures for human Upf3p and Upf2p were 
reported (26). The amino acid sequence within the NES-A region 
(residues 87-95 in S. cerevisiae) are 78% identical and 89% similar 
to human UPF3, suggested that the folded structure is likely to 
be similar in both organisms. The NES-A region lies within a 
three-dimensional structure that resembles an RNA recognition 
domain, but despite this, human Upf3p fails to bind to RNA. 
Instead, the NES-A region forms a β-sheet that is critical for the 
binding of Upf3p and Upf2p. Binding studies revealed that 
human Upf2p is capable of simultaneous binding to Upf3p and 
RNA, suggesting that a Upf2p/Upf3p complex may bind to 
RNA during export. 
 
Our genetic analyses combined with the structural analyses 
reported in Kadlec et al. (26) support a model in which Upf3p 
exports from the nucleus bound to Upf2p. Amino acid 
substitutions that impair the export of Upf3p result from an 
impaired interaction between Upf3p and Upf2p. Thus, NES-A 
directs nuclear export not by serving as a binding site for an 
exportin but rather as a binding site for Upf2p. The addition of 
the HIV-1 Rev-NES promotes export of mutant Upf3 proteins 
but it fails to restore the activity of the NMD pathway because 
the essential Upf3p/Upf2p interaction remains impaired. 
 
Adapting the dual selection to study other protein 
domains 
 
The results of our genetic analyses provide a proof of principle 
for using a dual selection to analyze the function of protein 
domains. Modifications could be made to study functional 
domains in other proteins. The best systems would be those 
where the crystal structure of a protein is known so that the 
effects of different amino acid substitutions could be more 
readily interpreted. The following considerations should guide 
the design of a dual selection to analyze domains in other 
proteins: 
 
(1) The domain to be studied must be self-contained, portable, 
and able to function out of context. The best way to test 
portability is to attach the domain of interest to a reporter. The 
C-terminus of a protein is likely the best position for attachment 
of a portable domain, but this would have to be tested 
empirically for any given system. Binding domains for DNA, 
RNA, protein, and small molecules are often self-contained and 
portable. However, active centers for enzymatic activities or 
other types of complex domains are often not portable since the 
active center is the result of protein folding rather than a 
contiguous amino acid sequence. 
 
(2) Since the selection is conducted in vivo, it is most readily 
adapted to study the products of genes that are dispensable for 
growth. In our studies, UPF3 is not essential for growth hence 
mutations do not reduce viability (5). For essential genes where 
the mutations of interest are potentially lethal, a condition would 
be needed where mutants are viable. Such a condition would vary 
depending on the gene being studied. 
 
(3) The phenotypic assays are critical in terms of the functions 
they monitor and the ease of scoring. At a minimum, the assays 
should include (a) a plate test for overall function of the protein 
that is amenable to mass screening (such as our assays for 
nonsense suppression), and (b) a specific assay for the function 
of the domain in which the mutations reside (such as the 
immunofluorescent localization assay we used for nuclear export 
and the two hybrid assay for protein-protein interactions). 
 
Mutations that cause partial impairment of function can be 
difficult to distinguish from wild-type, as was the case for upf3-
nes1, which is impaired only slightly (Table 1). Even for 
mutations causing greater impairment of function, suppression 
levels before and after recombination were not readily 
distinguished by examining the growth of colonies after replica-
plating. We resolved this by resorting to more sensitive serial 
drop tests to assay growth rates (7), but drop tests precluded the 
ability to screen large numbers of candidate mutants. Despite the 
fact that our system fell short of the ideal for phenotypic 
screening as described in Fig. 3, the basic idea behind the dual 
screen for loss/regain of function could prove useful in analyzing 
mutations in domains of other proteins using different 
phenotypic assays.  
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PROTOCOLS 
 
Protocols 
 
Protocols are written as performed for the sets of experiments described in the paper. General suggestions are given in brackets. To 
adapt the methods to study other genes, modifications of restriction sites, PCR conditions, choices of vectors, or other experimental 
parameters may be required. 
 
Plasmid Construction 
 
Insertion of loxP site after last codon and prior to termination codon of gene 
 
1.  Clone UPF3 into centromeric plasmid pRS314 between restriction sites SpeI and BstEII. 
2.  Removal of NotI site in the multiple cloning site of pRS314. {These steps can be eliminated if the vector containing the gene of 
interest does not contain a NotI site}. 
a.  Digest 5 µg of pLS17 with NotI (NEB) in a total volume of 50 µl at 37°C for hours.  
b.  Add 1µl of T4 DNA polymerase (NEB) and 100 µM of dNTPs at 16°C for 45 minutes to fill in 5' overhangs. {According to 
NEB, decreasing temperataure and incubation time to 12°C for 15 minutes reduces the occurrence of recessed ends caused by 
the 3' → 5' exonuclease activity of T4 DNA polymerase}.  
c.  Add 3µl of DNA, 4µl of T4 Ligase Buffer (Invitrogen), 13µl of H20 and 1µl of T4 Ligase, mix, incubate for 5 hours at 16°C. 
d.  Transform 2µl into subcloning competent DH5α cells (Invitrogen) according to manufacturer’s instructions. Plate 50, 100 and 
200µl of cell suspension following incubation at 37°C for 1 hour on LB plates containing 100 µg/ml ampicillin. Incubate at 
37°C for 18 hours. 
e.  Pick individual colonies and grow in 1 – 2 ml of LB liquid media containing 100 µg/ml ampicillin.  
f.  Isolate DNA by miniprep using Qiagen kit according to the manufacturer’s instructions.  
g.  Screen colonies for removal of NotI site and addition of FseI site. {If plasmids without NotI are a small percentage of plasmids 
recovered, pool colonies isolated in Step d. Isolate the DNA from the pooled colonies, cut with NotI and transform into 
DH5α.}. 
3.  Insertion of NotI site using Chameleon double-stranded site-direected mutagenesis kit (Strategene). 
a.  Synthesize an HPLC-purified olgionucleotide containing a 5'–end phosphate to insert a NotI site (GCGGCCGC) following the 
last codon and prior to the termination codon of UPF3. Synthesize a second oligonucleotide that changes the unique 
restriction site within pRS314.  
b.  Insert a NotI site into UPF3 using the oligonucleoties described above following manufacturer’s instructions.  
4.  To insert loxP, synthesize complementary oligonucleotides that contain a loxP site (underlined in the sequence below), generate 
NotI overhangs, and maintain the reading frame after ligation into plasmid generated in Step 3. To aid further cloning the 
oligonucleotides destroy the NotI site upon ligation and generate new restriction sites (AvrII, ClaI).   
a.  5' - GGC CTA GGA ATA ACT TCG TAT AAT GTA TGC TAT ACG AAG TTA TAT CGA TAT  
b.  5' - GGC CAT ATC GAT ATA ACT TCG TAT AGC ATA CAT TAT ACG AAG TTA TTC CTA 
c.  Combine 250 pmoles of each primer in a total volume of 100µl. Boil for 5 minutes and place immediately on ice. 
d.  Digest 1µg of vector generated in Step 3 with NotI in a total of 20µl. Clean-up digested vector using QIAquick PCR 
Purification Kit following manufacturer’s instructions. 
e.  Combine 2µl of digested vector, 1µl of annealed oligonucleotides diluted 1:10, 4 µl of T4 Ligase Buffer and 1µl T4 Ligase in 
20µl total. Mix gently. Maintain at room temperature for 1 hour. 
f.  Digest 3µl of the ligation reaction with NotI for 2 hours at 37°C. 
g.  Transform 2.5µl of the Not1-digested ligation into DH5α according to manufacturer’s instructions.  
h.  Isolate DNA by miniprep using Qiagen kit following manufacturer’s instructions. 
i.  Screen colonies for removal of NotI site, the addition of AvrII and ClaI restriction sites and by sequence analysis.  
j.  Sequence plasmid DNA to determine direction of the loxP site. The directional loxP sites must be in the same orientation for 
excision of the intervening sequence to occur after recombination.  
 
Insertion of 2nd loxP site downstream of gene insertion  
 
5.  Synthesize complementary oligonucleotides that contain a loxP site (underlined in the sequence below) and generate KpnI 
overhangs (Note: KpnI was chosen because it is a unique restriction site within the vector only). To aid in the cloning of ADE2 Shirley et al.    
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between the loxP sites and the addition of the NES element, destroy the 3' KpnI restriction site and replace with an XhoI restriction 
site (Note: depending on your sequence, it might be necessary to use a different restriction site). 
a.  5' - CAT AAC TTC GTA TAA TGT ATG CTA TAC GAA GTT ATC TCG AGC GTA C 
b.  5' - GCT CGA GAT AAC TTC GTA TAG CAT ACA TTA TAC GAA GTT ATG GTA C 
6.  Follow steps 4c to 4h (omit Step 4f) as described above. 
7.  Screen colonies for addition of loxP site by PCR, restriction digest and sequence analysis.  
 
Insertion of ADE2 between the loxP sites 
 
8.  Synthesize oligonucleotides to amplify ADE2 and include restriction sites for BstEII and KpnI. {We include six random nucleotides 
(N) at the end of the primer to increase efficiency of digestion of the PCR product by BstEII and KpnI.} 
a.  5' - NNN NNN GGT TAC CCA CCA ACA TAA CAC TGA CAT C 
b.  5' - NNN NNN GGT ACC CCT GAC GTA GCG CTA TCC 
9.  Set up a 50µl PCR reaction containing 1 – 2µl (0.2-0.4 µg) of S. cerevisiae genomic DNA, 1x Pfu Buffer, 50 pmoles primers, 200µM 
dNTPs. Begin cycling at 94°C for 3 minutes. After denaturation, pause cycle and add 1 µl of Pfu. Continue with 30 cycles of 94°C 
for 45 seconds, 50°C for 45 seconds, 72°C for 3 minutes followed by 72°C for 7 minutes. Check 10% of the PCR reaction on a 1% 
agarose gel to confirm size and purity of the amplified PCR product. 
10.  Add 50µl of TE(pH 8.0)-buffered-phenol:CHCl3, vortex, centrifuge on max speed for 1 minute, remove aqueous layer, repeat. Add 
50µl CHCl3, vortex, centrifuge on max speed for 1 minute, remove aqueous layer. Add 5µl NaOAc, 200µl EtOH to aqueous layer, 
place on ice for 10 minutes. Centrifuge on max speed for 5 minutes, wash pellet with 70% EtOH. Resuspend pellet in 50µl H20. 
{Alternatively, clean up the remaining PCR reaction using QIAquick PCR Purification Kit following manufacturer’s instructions.} 
11.  Digest 1µg plasmid isolated in Step 7 and 4 µl (~0.2 µg) ADE2 PCR product islolated above with BstEII and KpnI. Clean-up 
digested vector and PCR product using QIAquick PCR Purification Kit following manufacturer’s instructions. 
12.  Combine 5µl of digested vector, 6µl ADE2 PCR product, 4µl of T4 Ligase Buffer and 1µl T4 Ligase in 20µl total. Maintain at 
room temperature for 1 hour. 
13.  Transform 2µl of the ligation reaction into DH5α according to the manufacturer’s instructions. 
14.  Screen colonies for addition of ADE2 by restriction digest.  
 
Insertion of HIV-1 Rev NES 3' of 2nd loxP site   
 
15.  Synthesize complementary oligonucleotides that contain the HIV-1 Rev NES sequence (underlined in sequence below) with 
overhangs compatible with XhoI, generate a NotI restriction site and maintain the reading frame after loxP recombination. 
a.  5' – TCG AGT GCC ATT GCA ATT ACC ACC ATT GGA AAG ATT GAC TTT AGA TAG C 
b.  5' – GGC CGC TAT CTA AAG TCA ATC TTT CCA ATG GTG GTA ATT GCA ATG GCA C 
16.  Follow steps 4c-4h (omit step 4f) as describe above. 
17.  Screen colonies for addition of domain by PCR, restriction digest and sequence analysis.  
 
Insertion of the 3'-UTR of choice downstream of the domain of choice 
 
18.  Synthesize oligonucleotides to amplify the UPF3 stop codon and 3'-UTR and include restriction sites for NotI.  
a.  5' - NNN NGC GGC CGC GTC GAC TAG TAA AAG CTC ATG GCT TCT TAT AT 
b.  5' - NNN NGC GGC CGC GTA CCG TTT TTT AGT TCT ATG GTA ACC GTC TC 
19.  Set up a 50µl PCR reaction containing 1–2µl (0.2-0.4 µg) of S. cerevisiae genomic DNA, 1x Pfu Buffer, 50 pmoles primers, 200µM 
dNTPs. Begin cycling at 94°C for 3 minutes. After denaturation pause cycle and add 1µl of Pfu. Continue with 30 cycles of 94°C 45 
seconds, 50°C 45 seconds, 72°C 2 minutes followed by 72°C for 3 minutes.  
20.  Run 10% of the reaction on a 1% gel to confirm the size. Clean-up the remaining PCR reaction using QIAquick PCR Purification 
Kit following manufacturer’s instructions. Elute PCR product in 30µl H20. {Alternatively, use the clean-up procedure described in 
step 10 to purify PCR fragment}. 
21.  Digest 15µl of the PCR product with NotI for 2 hours at 37°C. Clean-up digested PCR product using QIAquick PCR Purification 
Kit following manufacturer’s instructions. Elute the PCR product in 30µl H20. 
22.  Digest 1µg of the vector with 1 unit of NotI for 2 hours at 37°C. After digestion add 1 unit of calf intestinal alkaline phosphatase 
(CIP). Incubate at 37°C for 15 minutes. Clean-up digested plasmid using QIAquick PCR Purification Kit following manufacturer’s 
instructions. Elute the vector in 30µl H20. 
23.  Combine 4µl of digested vector, 12µl 3'-UTR PCR product, 4µl of T4 Ligase Buffer and 1µl T4 Ligase in 20µl total. Maintain at 
room temperature for 1 hour. 
24.  Transform 3µl  of the ligation reaction into E. coli DH5α following manufacturer’s instructions. 
25.  Screen colonies for addition of 3’UTR by restriction digest and sequence analysis. Shirley et al.    
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Mutagenesis/library construction 
 
1.  Synthesize mutagenic oligonucleotide inserting random nucleotides within the four codons of UPF3 NES-A (see Materials and 
Methods and Fig. 2 for additional details on NES-A mutagenesis). 
a.  5' – CAA CCG AGA ATG AAG GAT TTA AG(A,C,G) (A,C,T,G)(A,C)G TT(A,C,G) (A,C,T,G)(A,C)A GA(A,C,G) 
(A,C,T,G)(A,C)(A,C,G) (A,C,T,G) (A,C)C CTC CAA ATT TGA CTG CAG ATG 
2.  Synthesize second oligonucleotide downstream of NES-A and unique restriction site SnaBI. 
a.  5' – CCA GTT CCA ACC AGC TCT G 
3.  Set up a 50µl PCR reaction containing 0.05µg plasmid generated in Step 25, 1x Pfu Buffer, 50 pmoles primers, 200µM dNTP mix. 
Begin cycling at 94°C for 3 minutes. After denaturation pause cycle and add 1µl of Pfu. Continue with 30 cycles of 94°C 45 
seconds, 47°C 45 seconds, 72°C 1 minute followed by 72°C for 3 minutes (PCR Round 1 in Fig. 2).  
4.  Run 10% of the PCR reaction on a 1% agarose gel to confirm PCR product. Clean-up the remaining PCR reaction using Qiagen 
QIAquick PCR Purification Kit following manufacturer’s instructions. Include an additional wash with 750µl of 35% guanidine 
hydrochloride prior to the Buffer PE wash step. Elute DNA in 50µl of H20. PCR fragment will be used as a megaprimer in the 
subsequent PCR reaction. 
5.  Synthesize T7 oligonucleotide upstream of NES-A and unique restriction site SacII. 
a.  5' – TAA TAC GAC TCA CTA TAG GG 
6.  Set up a 50µl PCR reaction containing 0.05µg plasmid generated in Step 25, 1x Pfu Buffer, 50 pmoles oligonucleotide, 25 - 50µl of 
megaprimer, 200µM dNTP mix. Begin cycling conditions of 94°C for 3 minutes. After denaturation pause cycle and add 1µl of Pfu. 
Continue with 30 cycles of 94°C 45 seconds, 47°C 45 seconds, 72°C 1 minute followed by 72°C for 3 minutes (PCR Round 2 in 
Fig. 2). 
7.  Run 10% of the PCR reaction on a 1% agarose gel to confirm PCR product. Clean-up the remaining PCR reaction using Qiagen 
QIAquick PCR Purification Kit following manufacturer’s instructions. Elute DNA in 50µl of H20.  
8.  Amplify PCR fragment using outside oligonucleotides from steps 2 and 5. Set up a 50µl PCR reaction containing 2µl PCR product, 
1x Pfu Buffer, 50 pmoles oligonucleotides, 200µM dNTP mix. Begin cycling conditions of 94°C for 3 minutes. After denaturation 
pause cycle and add 1µl of Pfu. Continue with 30 cycles of 94°C 45 seconds, 60°C 45 seconds, 72°C 2 minutes 30 seconds followed 
by 72°C for 3 minutes.  
9.  Digest 5µg of PCR fragment containing the mutated sequence in 1x restriction enzyme buffer and 5 units of SacII and SnaBI in 
100µl total volume at 37°C for 3 hours. Repeat with 5µg of plasmid generated above.  
10.  Run the digested products on a 1% agarose gel and gel purify the fragments using Qiagen QIAquick Gel Purification Kit following 
manufacturer’s instructions. Elute PCR product and digested vector in 50µl of H20.  
11.  Combine 4µl of digested vector, 4µl PCR product, 4µl of T4 Ligase Buffer and 1µl T4 Ligase in 20µl total. Maintain at 15°C 
overnight. As a control set up the same ligation reaction substituting H2O for the PCR product.  
12.  Transform 2µl of ligation reaction in XL-10 Gold Ultracompetent Cells (Stratagene) following manufacturer’s instructions. Plate 
200µl of the cell suspension onto each of 5 LB plates containing 100µg/ml ampicillin. Grow for 18 hours at 37°C.  
13.  Pool the cells on the plates by adding 1-2ml of LB containing 100µg/ml ampicillin to all the plates and gently removing the cells 
using a rounded-off end of a glass pipet.  
14.  Combine the cells from all plates and isolate plasmid DNA. 
 
Transformation of yeast  
 
To transform yeast by electroporation, use the Genepulser Electoporation apparatus from Biorad. Prepare cells according to (17) as 
follows: 
1.  Grow a fresh patch of the strain to be transformed on solid YEPD (yeast extract/dextrose) medium. Cells can be used for about 
one month. 
2.  Scrape cells from the patch with a toothpick and suspend in 20µl of 1M sorbitol plus 20mM HEPES.  
3.  Wash 2x in 1 mM sorbitol plus 20mM HEPES. 
4.  Pellet and resuspend in a suitable volume of 1M sorbitol plus 20mM HEPES. Each transformation requires a 40 µl cell suspension. 
5.  Add up to 1 µg of plasmid DNA in no more than 5µl to each transformation and transfer to a 0.2 cm electroporation cuvette.  
6.  Electroporate with the Biorad Genepulser set to 1.4 kV, 200Ω, 25µF. 
7.  Immediately add 0.25 ml of 1M sorbitol. Remove from the electroporation cuvette and plate on selective medium. 
 